Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol
Open Access

Epigenetic Responses to Controlled Ovarian Stimulation during Assisted Reproductive Procedures

Elena Marovic^{* *}Correspondence: Elena Marovic, Department of Reproductive Biology, North Coast Medical University, Split, Croatia, Email:

Author info »

Description

Controlled ovarian stimulation has become a routine part of assisted reproductive procedures across many fertility centers. The approach supports the development of multiple follicles during a single treatment cycle and allows clinicians to retrieve several mature oocytes for laboratory use. While pregnancy rates have improved during recent decades through modified stimulation plans and laboratory methods, scientific discussion has expanded toward the biological effects that ovarian stimulation may produce beyond immediate clinical outcomes. One area receiving increasing attention involves epigenetic activity within developing oocytes and early embryos.

Epigenetics refers to biochemical changes that influence gene activity without altering Deoxyribonucleic Acid (DNA) sequence. These modifications include DNA methylation, histone alteration, and small non-coding Ribonucleic Acid (RNA) activity. During follicular development, the oocyte undergoes extensive epigenetic programming that supports normal embryo growth after fertilization. Hormonal stimulation used in assisted reproduction may influence this process because supraphysiological hormone concentrations can alter the ovarian microenvironment. Researchers have examined whether these alterations influence embryo competence, implantation rates, placental development, or offspring health later in life.

Several investigations have compared natural ovulatory cycles with stimulated cycles to identify differences in methylation profiles. Animal studies have reported altered methylation patterns in genes associated with growth regulation and metabolic activity after exposure to elevated gonadotropin concentrations. Although direct translation of animal findings to human treatment requires caution, these observations have encouraged additional clinical evaluation. Human studies remain more limited due to ethical restrictions and difficulties in obtaining embryonic tissue for analysis. Even so, reports involving discarded embryos, follicular fluid, granulosa cells, and cord blood samples have contributed useful observations.

One topic frequently discussed involves genomic imprinting. Imprinted genes demonstrate parent-specific expression and rely heavily on accurate methylation marks established during gamete maturation. Improper imprinting may contribute to developmental disorders and abnormal placental function. Some investigators have identified slight variations in imprinting patterns among embryos generated through assisted reproduction compared with spontaneous conception. However, interpretation remains difficult because infertility itself may influence epigenetic regulation independently of medical intervention. Male factor infertility, advanced maternal age, endometriosis, and polycystic ovarian syndrome all demonstrate associations with altered epigenetic activity before treatment begins.

The ovarian follicle contains a highly coordinated environment composed of granulosa cells, immune mediators, hormones, growth factors, and metabolic substrates. During stimulation cycles, rapidly rising estradiol concentrations may affect communication between the oocyte and surrounding somatic cells. Certain studies have shown that excessive stimulation may reduce mitochondrial efficiency within oocytes, resulting in increased oxidative stress. Elevated reactive oxygen species can interfere with DNA methyltransferase function and histone regulation. This connection has generated interest in milder stimulation approaches designed to reduce hormonal exposure while maintaining acceptable oocyte yield.

Investigators from several reproductive centers have explored whether lower gonadotropin doses produce embryos with more stable epigenetic signatures. Preliminary findings suggest that moderate stimulation protocols may support improved synchronization between nuclear maturation and cytoplasmic maturation in the oocyte. This synchronization appears important for accurate chromosome segregation and post-fertilization development. Nonetheless, patient response varies considerably according to ovarian reserve, age, endocrine profile, and prior treatment history. For women with diminished ovarian reserve, aggressive dose reduction may compromise oocyte availability without providing measurable molecular benefit.

Cryopreservation methods also interact with the discussion surrounding epigenetics. Vitrification has largely replaced slow freezing because survival rates after thawing are generally higher. Some laboratory investigations have examined whether exposure to cryoprotective agents influences gene expression within embryos. Existing evidence indicates that vitrification appears relatively safe when performed under controlled laboratory conditions. However, subtle transcriptional alterations have been reported in some experimental models. Whether these observations carry long-term biological significance remains uncertain.

Clinical application of epigenetic knowledge remains limited at present. Most reproductive specialists continue to base stimulation protocols on ovarian reserve testing, prior response, and endocrine evaluation rather than molecular profiling. Even so, the field is moving toward greater personalization through integration of genomics, metabolomics, and transcriptomics. Future treatment planning may involve molecular assessment of follicular fluid or granulosa cells to estimate oocyte developmental capacity before fertilization occurs.

Conclusion

Large multicenter investigations with extended follow-up periods are still needed. Many current reports involve relatively small patient populations, inconsistent laboratory methods, and varying stimulation protocols. International collaboration may support stronger statistical interpretation and improve standardization across reproductive centers. Ethical oversight will remain highly important because studies involving human embryos require careful protection of patient autonomy and laboratory integrity. Assisted reproductive treatment now contributes to millions of births worldwide, and ongoing evaluation of treatment safety carries major importance for reproductive medicine. Epigenetic analysis offers one possible route toward improved understanding of how hormonal exposure during follicular development interacts with embryo formation and long-term offspring health. Continued scientific examination may support treatment strategies that maintain successful pregnancy outcomes while reducing unnecessary biological stress during assisted conception.